26 05, 2019 Libor Stanek et al., Expression level of NRP1 and SMAD2 in correlation to mutational status of RAS (BRAF) in pancreatic cancer. Diatech Pharmacogenetics2019-05-26T14:06:00+02:00 Mehr erfahren